search
for
 About Bioline  All Journals  Testimonials  Membership  News


Journal of Postgraduate Medicine
Medknow Publications and Staff Society of Seth GS Medical College and KEM Hospital, Mumbai, India
ISSN: 0022-3859 EISSN: 0972-2823
Vol. 48, Num. 1, 2002, pp. 21-24

Journal of Postgraduate Medicine, Vol. 48, Issue 1, 2002 pp. 21-24

An Analysis of Long-term Venous Access Catheters in Cancer Patients: Experience from a Tertiary Care Centre in India

Shukla NK, Das DK, Deo SVS, Raina V*

Departments of Surgical Oncology and Medical Oncology,* Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi - 110029, India.
Address for Correspondence: N. K.Shukla, MS, Department of Surgical Oncology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi -110029 E-mail: shuklank2@yahoo.com

Code Number: jp02005

Abstract:

Background: Venous access is crucial for administration of drugs blood products, antibiotics and periodic sampling in patients with cancer. Aims: To review our experience of longterm venous access devices used over a ten year period and to analyse the outcome in cancer patients in Indian setting. Setting and Design: A retrospective analysis of data in a tertiary care Regional cancer center. Patients and Methods: A total of 110 patients with various malignancies requiring longterm venous access were included in the study. A uniform open cut down procedure under local anaesthesia was used and silastic hickman catheters were inserted in the cephalic or external jugular or internal jugular veins. A record of all complications and catheter loss and final out come were analysed. Results: A total of 111 catheters were used in 110 patients. Sixty nine catheters were placed in cephalic, 40 in external jugular, and 2 in internal jugular vein. Duration of catheter indwelling period ranged from 7 to 365 days with a median of 120 days. In 90% of the cases the catheter tip was located either in superior vena cava or in right atrium. Total catheter related complications were observed in 37 (34.54%) patients and catheter loss rate due to complications was 15.4% (17/111). Conclusions: Long term venous access using Hickman catheter insertion by open cut down method is a simple, safe and reliable method for administration of chemotherapeutic agents, antibiotics and blood products. The incidence of various complications and catheter loss was acceptable and overall patient satisfaction was good.

Key Words: Prolonged Central venous access, Hickman Catheter, Open cutdown method.

Modern chemotherapeutic management of cancer patients depends upon repeated and prolonged access to venous system for safe and easy administration of various chemotherapeutic agents, antibiotics, intravenous fluids, blood components and blood sampling. Repeated venepunctures has various disadvantages and to overcome this problem arteriovenous fistulae, peripherally inserted silastic catheters and implantable venous ports have been tried with varying success.1,2 Silastic catheters described by Hickman and Broviac are most commonly used due to advantages like simple insertion technique, reliable patency and low complication rate.3,4 Venous access devices have been used widely in the western countries. However they are not commonly used in developing countries like India due to various reasons. We report our experience of 111 silastic Hickman catheter insertions in 110 cancer patients.

Patients and Methods

One hundred and ten cancer patients attending Institute Rotary Cancer Hospital (IRCH) of All India Institute of Medical Sciences (AIIMS), New Delhi during the period between January 1991 and December 2000 requiring prolonged venous access were taken up for Hickman catheter insertion. Routine pre-operative haemogram was done in all the patients to ensure minimum of 9 gm/dl haemoglobin and 100,000 per cubic mm of platelet count. Table- I shows the patient characteristics.

Technique of Hickman catheter Insertion

Uniform open cut down technique was used in all patients under strict aseptic precautions in the operation theatre. Right sided veins were mostly used in view of its direct course in to the right atrium. Left cephalic or jugular vein were only used when right cephalic or external jugular vein could not be accessed. 1% Lignocaine was used at the proposed site of venepuncture and along the subcutaneous plane on the chest wall for tunnelling the catheter 2 cms medial to anterior axillary line till the exit site 2 cms below the nipple. After localisation of the cephalic vein in the deltopectoral groove vein was looped using two separate 2-0 silk ligatures. Tunnelling was completed using a metallic tunneller designed by our team and the catheter was threaded with the help of tunneller in to the venotomy wound. The dacron cuff at the proximal end of the catheter was positioned in the subcutaneous tissue 2 cm proximal to the exit site and the catheter was anchored to the skin with a 2-0 silk suture. Required length of the catheter was determined by measuring the length of distance from venotomy site to sternal angle along the course of cephalic, subclavian and superior vena cava axis. Subsequently the distal suture was ligated securely over the cephalic vein and a venotomy was performed using venotomy scissors proximal to the distal ligature. After dilatation of the vein lumen by a vein dilator the catheter tip was threaded through venotomy and pushed inside to the desired length. During the catheter advancement manual pressure was applied over the internal jugular vein to prevent malposition of the catheter tip in internal jugular vein. Once the position of the catheter was secured and free flow of blood established, the proximal end of the vein was ligated over the catheter. After securing haemostasis, the wound was closed using 3-0 nylon. The catheter was flushed with heparinised saline 100 IU / ml and 1 gm of Cefotaxime was injected through the catheter at the end of the procedure. Whenever cephalic cutdown has failed external jugular vein was accessed through a separate incision. In patients with failed cephalic and external jugular vein cutdowns Internal jugular vein was accessed under general anaesthesia. Catheter was secured in Internal jugular vein using a 5-0 prolene purse string suture. A record of all complications and fate of the catheter was maintained. Catheter related sepsis was defined as I) Exit site infection - infection at catheter exit site II) Catheter blood culture proven bacteraemia in the absence of any other focus of infection III) Catheter tunnel infection- Signs of inflammation along the course of the tunnel IV) PUO-Pyrexia of unknown origin. The data was analysed using Fox Pro Windows version 2.5 (Microsoft Corporation, USA).

In hospital catheter care including aseptic precautions and periodic flushing of catheter before and after use was performed by a dedicated team of doctors and nurses. During this period the patient or a responsible attendant was also trained in catheter care and was also explained regarding the potential complications that can occur at home. When catheter was not used for long periods a weekly catheter flush using Heparin saline ( 100 IU/ml) was advised.

Results

A total of 111 catheters were used in 110 patients. Two catheters were used in one patient due to loss of first catheter due to rupture. Duration of catheter indwelling period ranged from 7 to 365 days with a median of 120 days. In 99 out of 111 (90%) cases catheter tip was located either in superior vena cava or in right atrium. Table 2 shows the site of catheter insertion and position of catheter tip.

Total catheter related complications occurred in 37 (34.5%) patients and total catheter loss due to complications were documented in 17 (15.4%) patients. Table 3 shows various catheter related complications. A total of 8 catheters (7.27%) were lost due to infective complications. Two-thirds of these cases had infection during the granulocytopenic phase of chemotherapy (TLC < 1000/dl). Exit site infection, catheter blood culture proven bacteraemia and PUO were seen in 3, 6, and 10 patients respectively. All 3 exit site infections were treated with local dressing and antibiotics. Seven out of 10 PUO and 1 out of 6 systemic bacteraemias were managed by giving systemic antibiotics. Five patients with blood culture proven bacteraemia and 3 patients with PUO did not respond to systemic antibiotics necessiating catheter removal. Staphylococcus aureus was found in 4 and candida albicans in 2 patients in blood culture proven bacteraemia cases while Staphylococcus aureus was found in 3 patients of PUO. A total of 9 catheters were lost due to non-infective complication. Seven (6.36%) catheters were lost due to blockage and, 1 catheter was lost due to extrusion and one due to rupture during infusion. Blockage of catheter occurred in 16 patients out of which 9 could be salvaged by flushing with heparin saline. One patient had supraventricular tachycardia during the insertion of the catheter which returned to normal sinus rhythm promptly on withdrawing the catheter. We did not encounter any haemorrhagic complications.

Discussion

The most disturbing aspect of treatment of a cancer patient is multiple painful venepunctures made for administration of cytotoxic agents, antibiotics, blood products and nutritional supplements. To overcome this problem arteriovenous fistulae, peripherally inserted silicone catheters, implantable ports have been tried with varying success.1,2 A number of clinical trials have favoured silastic Hickman catheters because of its simple insertion technique, reliable patency and short maturation time in comparison to other means of long term venous access.3,5 Two methods of Hickman catheter insertion have been described - 1) Open phlebotomy and 2) Closed percutaneous puncture technique. Open phlebotomy is much simpler and safer in comparison to closed technique which requires technical expertise and carries a higher complication rate like pneumothorax, haemo-pneumothorax and injury to great vessels.6 Post et al described ultrasound and fluoroscopy guided procedure of subclavian vein catheterisation with a very low complication rate but experience with this technique is limited. Fluoroscopy helps in proper placement of Hickman catheter tip even in open phlebotomy methods but its use is not mandatory. Despite not using routine fluoroscopy control we could achieve 90% success rate in positioning the catheter tip in large central veins. Only 11 catheters out of 111 could not be positioned in central veins. Satisfactory placement of catheter tip can be verified by a post operative chest x-ray.7 Cephalic cut down was performed in 63 % (69/111) patients in our series and our success rate of cephalic vein cannulation was comparable to the success rate quoted in literature.8,9 Torramed et al9 reported a success rate of 70% with cephalic cutdown and Wade et al8 reported 38 % successful cephalic cumulation rate. Failed cephalic cut down is mostly due to either small vein size or absence of the proper cephalic vein itself.6

Two-thirds of bacteraemias occurred in severely immune compromised infection prone patients in our series. Catheter related sepsis (17.27%) and catheter loss due to infective complications (7.27%) in our series was comparable to the results quoted by other series.6,10-12 Rao et al7 in an Indian experience of long term venous access using cavafix central venous lines reported a infection rate of 19% with subclavian lines and 32% with cubital lines.

Antibiotic prophylaxis is often recommended, as some studies showed low incidence of septic complications by using prophylactic antibiotics.13,14,15 Raad et al16 using a non tunnel technique reported low complication rate and increased durability of catheters but the experience with this method is limited. The catheter blockage rate in the current study is 14.5% in comparison to 13% reported by Rao, et al.7 Only flushing of blocked catheter using 20 ml of heparin saline (100 iu/ml ) solution was attempted to clear the block in the current study and 9 out of 16 catheters could saved. No thrombolytic agents like urokinase or streptokinase13 were used to clear the blocks due to cost factors.

Absence of haemorrhagic complications in our study can be attributed to strict adherence to a minimum platelet count of 100,000 per cubic mm. There was no catheter related mortality in our series and overall patients satisfaction was excellent.

In conclusion, long term venous access using Hickman catheter is a safe and reliable method for administration of chemotherapeutic agents and other intravenous components in the management of various malignancies. Results of our study prove that open cut down method for Hickman catheter insertion is safe with a low complication and high success rate and they can be maintained safely at home. Routine insertion of such devices can save valuable time of medical and para medical staff. Based on our experience, we feel that these catheters can be widely used in country like India as a means of prolonged venous access in the management of various malignancies.

References

  1. Steckler RM,. Martin RG, Speer JF, Mc Credie KB. Vascular access by means of surgically created arteriovenous fistulas in the chemotherapy of acute leukemias. A preliminary report. South Med J 1974;67:821-2.
  2. Gyves J, Ensminger W, Neiderhuber J, Liepman M, Cozzi E, Donn K, Dakhil S, Wheeler R. Totally implantable system for intravenous chemotheraoy in patients with cancer. Am J Med 1982;73:841 - 45.
  3. Boviac JW, Cole JJ, Scribner BH. A silicon rubber arterial catheter for prolonged parenteral alimentation. Surg Gynaecol Obstet 1973;136:602-6.
  4. Reed WP, Newman KA, De Jongh C, Wade JC, Schimpff SC, Wiernik PH, Mclaughlin JS. Prolonged venous access for chemotherapy by means of Hickman catheter. Cancer 1983;52:185-90.
  5. Mullen F, Hood JM, Barros D. Use of Hickman catheter for central venous access in patients with haematological disorders. Br J Clin Pract 1992;46:167-70.
  6. Stephen P, Povoski. A prospective analysis of the cephalic vein cut down approch for chronic indwelling central venous access in 100 consecutive cancer patients. Anals Surg Oncol 2000;7:496-502.
  7. Konety Rao V, Charak BS, Giri NK, Banavali SD, Pai SK, Pai VR, et al. Cytotoxic therapy; role of durable venous access. J Assoc Physicians India 1990;l38:897-9.
  8. Wade JC, Newman KA, Schimpff SC, Van Echo DA, Gelber RA, Reed WP, Wiernik PH. Two methods for improved venous access in acute leukemia patients. JAMA 1981;246:140-4.
  9. Torramade JR, Cinfuegos JA, Hernandez JI, Prado F, Benito C,Gonzalez J. The complications of central venous access systems: a study of 218 patients. Eur J Surg 1993;159:323-7.
  10. Gvenier C, Ferreira J, Pector JC. Prolonged venous access in cancer patients. Eur J Surg Oncol 1989;15:553-5.
  11. Ross MN, Haase GM, Poole MA, Burrington JD, Odem LF. Comparison of totally implantable resorvoirs with external catheters as venous access devices in paediatric oncology patients. Surg Gynaecol Obstet 1988;167:141-4.
  12. Nightingale CE, Norman A, Cunningham D, Young J, Webb A, Filshie J. A prospective analysis of 949 long term central venous accesss catheters for ambulatory chemotherapy in patients with gastrointestinal malignancices. Eur J Cancer 1997;33:398-403.
  13. Vincent J. Nill O, Jeffrey Evans TR, Janice Preston, John Moss, Stanley Bernard Kaye. A retrospective analysis of Hickman Line-Associated Complications in Patients with Solid Tumours Undergoing Infusional Chemotherapy. Acta Oncologica 1999; 38:1103-7.
  14. Lim SH, Smith MP, Salooja N. A prospective randomised syudy of profilactive teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for hematoligical malignancies. J Antimicrob Chemother 1991;28:109-16.
  15. Raff JH. Results from use of 826 vascular access devices in cancer patients. Cancer 1985;55:1312-21.
  16. Raad I, Davis S, Becker M, Hohn D, Houston D, Umphrey J, Bodie GP. Low infection rate and long durability of non tunneled silastic catheters. A safe and cost effective alternative for long term venous access. Arch Int Med 1993;153:1791-6.

This article is also available in full-text from http://www.jpgmonline.com/

© Copyright 2002 - Journal of Postgraduate Medicine


The following images related to this document are available:

Photo images

[jp02005t3.jpg] [jp02005t2.jpg] [jp02005t1.jpg]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil